Last reviewed · How we verify
Iron supplement A
Iron supplement A provides bioavailable iron to replenish depleted iron stores and support hemoglobin synthesis.
Iron supplement A provides bioavailable iron to replenish depleted iron stores and support hemoglobin synthesis. Used for Iron deficiency anemia.
At a glance
| Generic name | Iron supplement A |
|---|---|
| Sponsor | Tanabe Pharma Corporation |
| Drug class | Iron supplement |
| Target | Iron (Fe2+/Fe3+) |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Mechanism of action
Iron is an essential mineral required for the formation of hemoglobin and myoglobin, which transport and store oxygen in the blood and muscles. By supplementing iron, this product corrects iron deficiency anemia by restoring adequate iron levels needed for normal red blood cell production and oxygen-carrying capacity. The specific formulation and absorption characteristics depend on the iron salt and any chelation or delivery technology used by Tanabe Pharma.
Approved indications
- Iron deficiency anemia
Common side effects
- Gastrointestinal upset (nausea, constipation, abdominal discomfort)
- Dark stools
- Abdominal pain
Key clinical trials
- Iron and Immune Response to Vaccine (IRONMUM) (NA)
- Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial (PHASE2)
- Iron Absorption and Losses in Young South African Women Living Without and With Overweight and Obesity (NA)
- Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women (PHASE4)
- Effectiveness and Acceptability of LISEFEX® (Liposomal Iron With Vitamin C and Fiber) in People With Iron Deficiency Anemia.
- Child Health, Agriculture and Integrated Nutrition (NA)
- Assessing Dietary Intake of Selected Food Components Using Short Questionnaires
- Iron Absorption From IFA and MMS Supplements in Kenyan Women During the Second Trimester of Pregnancy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Iron supplement A CI brief — competitive landscape report
- Iron supplement A updates RSS · CI watch RSS
- Tanabe Pharma Corporation portfolio CI